Jubilant Life surges 9%, PAT rises 437% in Dec quarter

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Moneycontrol Bureau

Shares of Jubilant Life Sciences surged 9 percent intraday on Friday riding high on its December quarter results. Its net profit jumped 437 percent to Rs 143.43 crore for the third quarter ended December 2013, up from Rs 26.69 crore year-on-year.

Its total income grew 10 percent growth at Rs 1,442.78 crore in the quarter against Rs 1,306.39 crore in a yearly basis.

The company feels that revenues and EBIDTA are expected to improve in the coming quarters led by improved capacity utilisations in sterile injectables and OCL, nutrition ingredients, Symtet and 3CP, backward integration of Pyridine and expansion to newer markets. “We expect revenue growth due to strong pipeline in APIs and solid dosage formulations, new product launches, expansion in newer geographies in API and Formulations, and robust order book in sterile injectables,” it says in a statement.

At 11:47 hrs Jubilant Life Sciences was quoting at Rs 139.70, up Rs 7.25, or 5.47 percent.